Cara Therapeutics CEO Christopher Posner's 2022 pay falls 75% to $2.5M
Cara Therapeutics reports 2022 executive compensation
By ExecPay News
Published: April 20, 2023
Cara Therapeutics reported fiscal year 2022 executive compensation information on April 20, 2023.
In 2022, three executives at Cara Therapeutics received on average a compensation package of $2M, a 54% decrease compared to previous year.
Average pay of disclosed executives at Cara Therapeutics
Christopher Posner, Chief Executive Officer, received $2.5M in total, which decreased by 75% compared to 2021. 36% of Posner's compensation, or $898K, was in option awards. Posner also received $200K in bonus, $294K in non-equity incentive plan, $700K in salary, $408K in stock awards, as well as $9.8K in other compensation.
Ryan Maynard, Chief Financial Officer, received a compensation package of $1.9M. 90% of the compensation package, or $1.7M, was in option awards.
Joana Goncalves, Chief Medical Officer, earned $1.6M in 2022, a 11% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 20, 2023.